Summary
The clinical results obtained in 81 cases of bladder tumor are used as a basis for discussion of factors influencing the effect of bladder instillation therapy. The following conclusions are derived: 1) If bladder instillation therapy aims only at complete remission (CR), tumors over 1 cm in diameter should be excluded, because this is the theoretical size limit beyond which instillation therapy cannot lead to CR. 2) At least 40 ml of drugs may be needed for instillation therapy for tumors located in area B, the limited part posterior to the trigonum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Araki H, Mishina T, Miyakoda K, Fujiwara T, Kobayashi T (1982) Cytosine arabinoside bladder instillation therapy for bladder tumors. Tohoku J Exp Med 136:23
Japanese Urological Association & Japanese Pathological Society (1980) General rule for clinical and pathological studies on bladder cancer. Kanehara, Tokyo, p 10
Mishina T, Oda K, Murata S, Ohe H, Mori Y, Takahashi T (1975) Mitomycin C bladder instillation therapy for bladder tumors. J Urol: 217
Mishina T, Fujiwara T, Miyakoda K, Araki H, Kobayashi T, Saitoh M, Watanabe H (1979) Adriamycin instillation therapy for bladder tumors. Tohoku J Exp Med 127: 339
Mishina T, Watanabe H, Kobayashi T, Maegawa M, Nakao M, Nakagawa S (1986) Absorption of anticancer drugs through bladder epithelium. Urology 27: 148
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watanabe, H., Nakao, M., Nakagawa, S. et al. Size and location of tumors influencing the effect of bladder instillation therapy. Cancer Chemother. Pharmacol. 20 (Suppl 1), S49–S51 (1987). https://doi.org/10.1007/BF00262485
Issue Date:
DOI: https://doi.org/10.1007/BF00262485